Association Between Using Hair Dyes and Cancer Risk in a Population

Introduction

Hair dyes are used by millions of people, so even a modest change in cancer risk could matter at the population level. The scientific question is complicated because “hair dye” is not a single exposure. Products may be permanent, semi-permanent, or temporary; formulas have changed over time; darker permanent dyes can use different concentrations of chemical intermediates; and occupational exposure among hairdressers differs substantially from occasional personal use. Cancer is also not one outcome. Research has examined bladder cancer, breast cancer, non-Hodgkin lymphoma, leukemia, ovarian cancer, and other malignancies, sometimes with different findings across study designs and populations (White et al., 2020). Current evidence does not justify saying that all personal hair-dye use causes cancer, but it also does not support the idea that these exposures are irrelevant. A careful population study should therefore measure product type, shade, frequency, duration, calendar period, application setting, and occupational exposure rather than classifying participants only as users and nonusers.

Current Evidence and Research Question

Scientific concern arose partly because older permanent hair-dye formulations contained aromatic amines that produced cancer in laboratory research. Manufacturers removed several of these ingredients during the 1970s, which means historical exposure is not necessarily comparable with use of modern products. The International Agency for Research on Cancer has classified occupational exposure as a hairdresser or barber as probably carcinogenic to humans, while personal use of hair dyes has been considered not classifiable as to carcinogenicity because available evidence is limited or inconsistent across outcomes (International Agency for Research on Cancer, 2010). The National Cancer Institute similarly summarizes a mixed evidence base for personal use and emphasizes that risk may differ according to formulation, use pattern, and cancer type.

For personal users, large observational studies have not produced one uniform result. Some research has reported no clear overall association with particular cancers, while other studies have observed modest associations in selected subgroups or with certain products. White and colleagues, for example, reported associations between permanent dye or straightener use and breast-cancer risk in a large U.S. cohort, with patterns differing across participant groups (White et al., 2020). Another prospective cohort analysis of U.S. women found no overall increase in most cancers or cancer mortality among personal permanent-dye users, while reporting associations for some outcomes and subgroups that required cautious interpretation (Shah et al., 2020). These findings support further investigation but do not establish that every permanent dye has the same effect or that an observed association is necessarily causal.

A focused research question would be: Among adults without a previous cancer diagnosis, is long-term personal use of permanent hair dye associated with the incidence of selected cancers compared with no personal hair-dye use? A reasonable hypothesis is that frequent, long-duration use of permanent dye—particularly darker shades or products first used before major reformulation—may be associated with a small increase in the incidence of selected cancers. The study should nevertheless be designed to detect increased risk, decreased risk, or no meaningful difference rather than assuming the direction of the result in advance.

Study Design and Exposure Measurement

A prospective cohort design is more appropriate than deliberately assigning people to long-term potentially harmful exposure. Researchers could enroll a large group of adults, document existing hair-product practices, and follow participants over time while identifying cancer outcomes through medical records, pathology reports, or cancer registries. Because many cancers are relatively uncommon and may develop after long latency periods, a study of only a few thousand people followed for five years would probably have limited statistical power. A stronger design would enroll tens of thousands of participants and continue follow-up for at least a decade, while a smaller sample could function as a pilot for testing recruitment, exposure measurement, and retention procedures.

Exposure should be measured in enough detail to reflect the chemical and historical differences among products. Relevant variables include whether the product is permanent, semi-permanent, or temporary; natural hair color and usual dye shade; age and calendar year at first use; total years of use; applications per year; whether dye is self-applied, used at home by another person, or applied professionally; brand or ingredient information when available; glove use and ventilation; scalp irritation or burns; and employment as a hairdresser, barber, cosmetologist, or salon worker. Exposure should also be updated during follow-up because people may change products, stop dyeing, or begin using dye after enrollment. Treating exposure as fixed at baseline can misclassify participants and weaken the analysis.

Confounding, Bias, and Statistical Analysis

A valid comparison requires careful measurement of factors associated with both exposure and cancer risk. Important potential confounders include age, sex, family history, tobacco use, alcohol consumption, body mass index, reproductive history, hormone use, occupational chemical exposure, ultraviolet exposure, socioeconomic status, healthcare access, and use of other hair products. These variables should be measured consistently in both exposed and comparison groups. Smoking, for example, should not be built into the group definition by placing smokers in one group and never-smokers in another. It should be recorded as never, former, or current use, with duration and intensity where possible, and then addressed analytically. The same principle applies to body mass index and other risk factors: unnecessary restriction can reduce generalizability when adjustment would provide a more representative study.

Bias also requires active management. Recall bias may occur when participants cannot remember products used many years earlier, even in a prospective study that measures current exposure before cancer develops. Product photographs, brand lists, salon records, and repeated questionnaires can improve accuracy. Selection bias can arise if people who volunteer for a hair-product study differ systematically from the general population, so recruitment should use multiple settings rather than relying only on salon clients or highly health-conscious volunteers. Loss to follow-up should be monitored because participants who withdraw may differ in exposure, health, or income. Detection bias is possible if users receive more medical screening than nonusers, making healthcare utilization another variable worth measuring.

Incidence rates should be calculated for prespecified outcomes, and time-to-event models can estimate hazard ratios while adjusting for confounders. Exposure can be analyzed as never, former, and current use; cumulative applications; duration; product type; shade; and period of first use. Dose-response patterns are more informative than one yes-or-no comparison. Subgroup analyses may be scientifically useful, but they increase the probability of chance findings and should therefore be specified before analysis when possible. Confidence intervals and absolute risk are essential because a statistically detectable association may still correspond to a small change in population risk.

Ethics and Interpretation

A randomized human trial assigning participants to years of potentially harmful chemical exposure would be neither ethical nor practical. Causal inference must instead be strengthened through consistent findings across cohort and occupational studies, exposure-response relationships, biological plausibility, improved exposure measurement, and natural experiments created by changes in product formulation. Laboratory and animal research can help identify hazards, but doses and exposure routes may differ from personal human use. No single study can resolve the question by itself; risk assessment depends on evidence from multiple methods.

Participants should give informed consent for questionnaires, registry linkage, and any biological samples. Privacy protections are necessary because medical, occupational, and consumer-product information is sensitive. Recruitment material should explain the uncertainty without alarming people by implying that personal hair-dye use is already known to cause cancer or reassuring them that it has been proven harmless. Researchers may provide basic safety information consistent with product instructions—such as using gloves, adequate ventilation, and avoiding application to damaged skin—while distinguishing general exposure reduction from a claim that cancer risk has been established. Occupational users deserve particular attention because their cumulative exposure and frequency can be substantially higher than those of personal users.

Conclusion

The relationship between personal hair-dye use and cancer cannot be answered reliably by dividing a small population into simple “user” and “nonuser” groups. Product chemistry, historical reformulation, shade, frequency, duration, occupational exposure, and cancer type all matter. Current evidence is mixed for personal use and more concerning for some occupational exposures, which is why broad claims in either direction are inappropriate. A strong prospective cohort would enroll a large and diverse population, measure exposure repeatedly and in detail, verify outcomes through cancer registries or medical records, and adjust carefully for confounding variables. Such a design would be better able to identify whether particular products, historical periods, use patterns, or occupational settings are associated with meaningful changes in risk while avoiding the misleading conclusion that every hair dye and every user face the same exposure.

References

International Agency for Research on Cancer. (2010). Some aromatic amines, organic dyes, and related exposures. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 99.

National Cancer Institute. Hair dyes, other hair products, and cancer risk.

Shah, K. S., Baptiste, B. A., & Leffell, D. J. (2020). Personal use of permanent hair dyes and cancer risk and mortality in US women: Prospective cohort study. BMJ, 370, m2942.

White, A. J., Sandler, D. P., Gaston, S. A., & Jackson, C. L. (2020). Use of permanent hair dyes and straighteners and breast cancer risk in a large US population of Black and White women. International Journal of Cancer, 147(2), 383–391.

Editorial Staff

Academic Master Education Team is a group of academic editors and subject specialists responsible for producing structured, research-backed essays across multiple disciplines. Each article is developed following Academic Master’s Editorial Policy and supported by credible academic references. The team ensures clarity, citation accuracy, and adherence to ethical academic writing standards

Content reviewed under Academic Master Editorial Policy.

• Editorial Staff

  Why Secured Parking and Controlled Access Should Be on Every Costa Mesa Daycare Checklist
• Editorial Staff

  How to Prepare a Basement for Painting
• Editorial Staff

  Leadership and Innovation at Freedom Holding Corp
• Editorial Staff

  Best Magic Hour Image to Video of 2026: Create Stunning AI Videos from Photos